Nektar Therapeutics
NKTR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35,522 | -$41,593 | -$50,882 | $7,261 |
| Dep. & Amort. | $196 | -$655 | $426 | $332 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,072 | $3,486 | $3,898 | $4,803 |
| Change in WC | -$10,165 | -$3,581 | -$146 | -$11,515 |
| Other Non-Cash | -$6,342 | -$3,395 | -$2,349 | -$47,068 |
| Operating Cash Flow | -$48,761 | -$45,738 | -$49,053 | -$46,187 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$114 | -$37 | -$2 | -$459 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$149,558 | -$18,921 | -$24,931 | -$69,827 |
| Inv. Sales/Matur. | $54,799 | $68,573 | $69,319 | $65,114 |
| Other Inv. Act. | $0 | $0 | -$697 | $65,386 |
| Investing Cash Flow | -$94,873 | $49,615 | $43,689 | $60,214 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $141,677 | $211 | $7 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $83 |
| Financing Cash Flow | $141,677 | $211 | $7 | $83 |
| Forex Effect | $1 | $6 | -$1 | $33 |
| Net Chg. in Cash | -$1,956 | $4,094 | -$5,358 | $14,143 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42,988 | $38,894 | $44,252 | $30,109 |
| End Cash | $41,032 | $42,988 | $38,894 | $44,252 |
| Free Cash Flow | -$48,875 | -$45,775 | -$49,055 | -$46,646 |